The Filing Desk

Tandem Diabetes Care vs Varex Imaging

Tandem Diabetes Care TNDM · Varex Imaging VREX · Health Care Equipment

Tandem Diabetes Care reported revenue of $1.0 billion in fiscal 2025, 1.2 times Varex Imaging's $845 million in fiscal 2025. Tandem Diabetes Care's revenue grew 7.9% in its latest year, and Varex Imaging's grew 4.1%. Tandem Diabetes Care had an operating margin of -18.4%, against -3.3% at Varex Imaging. Free cash flow was −$30 million at Tandem Diabetes Care and $19 million at Varex Imaging. Their fiscal years end in different months (December 31 and October 3), so the periods don't line up exactly.

Side by side

Tandem Diabetes CareVarex Imaging
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Oct 3, 2025
Revenue$1.0B$845M
Revenue growth7.9%4.1%
Revenue growth a year, last 5 years15.3%2.7%
Gross margin53.8%34.4%
Operating margin−18.4%−3.3%
Net margin−20.2%−8.3%
Free cash flow−$30M$19M
Free cash flow margin−2.9%2.2%
Return on capital−85.5%−2.9%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count2.8%1.5%
Last close$20.07$18.10
P/E at the last close—34.2×
Insider trades, last 12 monthssold $36,911—
Piotroski F-score4 of 96 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Tandem Diabetes CareVarex Imaging
Operating margin
Percent of revenue
Tandem Diabetes CareVarex Imaging
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Tandem Diabetes CareVarex Imaging

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Tandem Diabetes Care and Varex Imaging pages.